Mike McDermott, MD

Recognitions

• Top Doctors in Denver, 5280 Magazine, 2004-2025 (2025)
  Voted a 5280 best doctor by my peers in response to the question, "Which physician would you trust to treat you and your family?"
• Clinical Excellence Society, Department of Medicine (2024)
  Inaugural Cohort
• Excellence in Clinical Innovation Award, University of Colorado Hospital (2022)
  Diabetes Home and Remote Care Center (DHRC)
• Distinguished Physician Award, CU School of Medicine (2022)
• Distinguished Service Award, University of Colorado Hospital (2017)
• Distinguished Physician of the Year, The Endocrine Society (2013)
  
• Outstanding Physician Award, University of Colorado Hospital (2012)
• Medical Student Teaching Award, CU School of Medicine (2011)
• Outstanding Clinical Teacher, University of Colorado Medical School, Kaiser Permanente (2009)
  
• Outstanding Physician Award, University of Colorado Hospital (2004)

Research Interests

My research focuses include Diabetes Mellitus, Metabolism, Osteoporosis and Thyroid Disease.

Publications

• Clina JG, Sayer RD, Pan Z, Cohen CW, McDermott MT, Catenacci VA, Wyatt HR, Hill JO. High and normal protein diets improve body composition and glucose control in adults with type 2 diabetes: A randomized trial. Obesity 2023; 31:2021-2030. PMID: 37475689
• Low Wang CC, Seggelke SA, McDermott MT, Reusch JEB. Pathophysiology: How Covid-19 impacts the pancreas and peripheral insulin resistance. In: Myers AK, Ed. Diabetes and Covid-19: Considerations and Clinical Management. Springer, 2023
• McDermott MT, Trujillo J. Diabetes Secrets (1st edition). Philadelphia, Elsevier, 2022.  
• McDermott MT. In the Clinic: Hyperthyroidism. Ann Intern Med 2020 April 7; 172(7):ITC49-ITC64. PMID:32252086
• McDermott MT. In the Clinic: Hypothyroidism. Ann Intern Med 2020 July 7; 173(1):ITC1-ITC16. PMID: 32628881
• Kwak JJ, Altoos R, Jensen A, Altoos B, McDermott MT. Increased risk of radioiodine treatment failure associated with Graves’ disease refractory to methimazole. Endocrine Practice 2020; 26:1312-1319.
• McDermott MT. Overview of the Clinical Manifestations of Hypothyroidism. In: Braverman LE, Cooper DS, Kopp P, eds. Werner & Ingbar's The Thyroid: A Fundamental and Clinical Text. 11th ed. Philadelphia, PA: Wolters Kluwer, 2020. Pp. 575-583.
• McDermott MT. In the Clinic: Hyperthyroidism Update. Ann Intern Med 2020; (in press)
• Reynolds PM, DeSalvo K, Mizukami-Stout KR, Barber GR, McDermott M. Impact of endocrinologist and clinical pharmacist interventions on reducing the potentially inappropriate use of levothyroxine in hospitalized patients. (submitted - positive reviews)
• McDermott MT. Overview of the Clinical Manifestations of Hypothyroidism. In: Braverman LE, Cooper DS, eds. Werner & Ingbar's The Thyroid: A Fundamental and Clinical Text. 11th ed. Philadelphia, PA: Lippincott Williams & Wilkins, 2020.
• Draznin B, McDermott M. Infrastructure of a Diabetes Clinics and Centers to Support Diabetes Technology. In Hirsch I, Edelman S, Klonoff, Draznin B (eds.), Diabetes Technology – Science and Practice, 2019. Chapter 2, p. 15-23
• McDermott MT. Metabolic Bone Disease. In: West SG, ed. Rheumatology Secrets (4th edition). Philadelphia: Elsevier, 2019; Chapter 52, p. 421-29.
• McDermott MT. Bone Strengthening Agents. In: West SG, ed. Rheumatology Secrets (4th edition). Philadelphia: Elsevier, 2019; Chapter 87, p.699-709
• McDermott MT, ed. Endocrine Secrets (7th edition). Philadelphia, Elsevier, 2019.
• McDermott MT, ed. Management of Patients with Pseudo-Endocrine Disorders. A Case-Based Pocket Guide. New York, Springer Nature, 2019.
• McDermott MT. Hypothyroidism. In: Cooper DS, Sipos JA (eds.), Medical management of thyroid disease (3rd ed.). CRC Press, Taylor and Francis Group, Boca Raton, Fl. 2019. Pp. 129-158.
• McDermott MT, ed. Endocrine Secrets (7th edition). Philadelphia, Elsevier, 2019
• McDermott MT. Metabolic Bone Disease. In: West SG, ed. Rheumatology Secrets (4th edition). Philadelphia: Elsevier, 2019
• McDermott MT. Bone Strengthening Agents. In: West SG, ed. Rheumatology Secrets (4th edition). Philadelphia: Elsevier, 2019
• McDermott MT. Hypothyroidism. In: Cooper DS, Sipos (eds.), Medical management of thyroid disease (3rd ed.). New York: Informa Healthcare, 2019
• McDermott MT. Overview of the Clinical Manifestations of Hypothyroidism. In: Braverman LE, Cooper DS, eds. Werner & Ingbar's The Thyroid: A Fundamental and Clinical Text. 11th ed. Philadelphia, PA: Lippincott Williams & Wilkins, 2019
• Draznin B, McDermott M. Infrastructure of a Diabetes Clinic/Center to Support Diabetes Technology. In Hirsch I, Edelman S, Klonoff, Draznin B (eds.), Diabetes Technology – Science and Practice, 2019
• Davis SN, Mayson S, Albuja Cruz M, Raeburn C, McIntyre R, Haugen BR, McDermott MT. Levothyroxine dosing after total thyroidectomy in the obese population: are we reaching our goals. 88th Annual Meeting of the American Thyroid Association in Washington DC, October 4-7, 2018
• McDermott MT, ed. Management of the Pseudo-Endocrine Patient: A Practical Case-Based Approach. New York, Springer Nature
• Schmidt RL, LoPresti JS, McDermott MT, Zick SM, Straseski JA. Is reverse triiodothyronine ordered appropriately? Data from reference lab shows wide practice variation in orders for reverse triiodothyronine. Thyroid 2018; 28(7):842-848.
• Pearson SM, Trujillo JM, McDermott MT. 5-alpha-dihydrotestosterone elevations associated with phentermine use. Therapeutic Advances in Endocrinology and Metabolism 2018; 9(8):255-258.
• Schmidt RL, McDermott MT, LoPresti JS, Zick S, Straseski JA. Is reverse triiodothyronine ordered appropriately? Data from reference lab shows wide practice variation in orders for reverse triiodothyronine. (in press)
• Hypothyroidism. In, Medical Management of Thyroid Disorders. Cooper D, Sipo J (eds). (in press)
• Golightly LK, Barber GR, Stoplman NM, Kick SD, McDermott MT. Hypoglycemic effects of tramadol analgesia in hospitalized patients. J Diabetes and Metabolic Disorders 2017; 16:30-38.
• Santoro N, Braunstein GD, Butts CL, Martin KA, McDermott M, Pinkerton JV. Compounded Bioidentical Hormones in Endocrinology Practice: An Endocrine Society Scientific Statement. J Clin Endocrinol Metab 2016; 101 (4):1318-43. PMID: 27032319
• Saxon D, McDermott M, Michels A. Novel Management of Insulin Autoimmune Syndrome with Rituximab and Continuous Glucose Monitoring. J Clin Endocrinol Metab 2016; 101:1931-4
• Wieland A, Mettler P, McDermott M, Crane LA, Cicutto L, Bambha KM. Low awareness of nonalcoholic fatty liver disease (NAFLD) among patients at high metabolic risk. J Clin Gastroenterology 2015 Jan; 49:e6-e10-16. PMID: 24440943
• Nuffer W, Gilliam E, McDermott M, Turner CJ. Sustainability of a practice-based interprofessional introductory pharmacy practice experience course. Am J Pharmaceutical Edu 2015; 79:1-6.
• Vigersky RA, Fish L, Hogan P, Stewart A, Kutler S, Ladenson PW, McDermott M, Hupart KH. The Clinical Endocrinology Workforce: Current Status and Future Projections of Supply and Demand. J Clin Endocrinol Metab 2014; 99:3112-21.
• Rothman MS, West SG, McDermott MT. Clinical challenge: osteoporosis for the practicing Neurologist. Neurology Clinical Practice 2014; 4(1):34-43
• Wieland A, McDermott M, Bambha K. Low awareness of nonalcoholic fatty liver disease (NAFLD) among patients at high metabolic risk. J Clin Gastroenterol 2014 Jan 16 (Epub ahead of print)
• Rothman MS, West SG, McDermott MT. Clinical challenge: osteoporosis for the practicing Neurologist. Neurology Clinical Practice 2014; 4(1):34-43.
• Wieland A, McDermott M, Bambha K. Low awareness of nonalcoholic fatty liver disease (NAFLD) among patients at high metabolic risk. J Clin Gastroenterology 2014 Jan 16 (Epub ahead of print). PMID: 24440943
• McDermott MT, ed. Endocrine secrets (6th edition). Philadelphia, Elsevier, 2013.
• Kartalija M, Ovrutsky AR, Bryan CL, Pott GB, Fantuzzi G, Thomas J, Strand MJ, Bai X, Ramamoorthy P, Rothman M, Nagabhushanam V, McDermott M, Levin A, Korner J, Iseman MD, Shapiro L, Chan ED. Patients with non-tuberculous Mycobacterial lung disease exhibit a distinct body morphotype with altered cytokine and adipokines profiles. Am J Respir Crit Care Med 2013; 187(2):197-205
• King WM, McDermott MT, Trujillo JM. Initial management of severe hyperglycemia in patients with type 2 diabetes in the outpatient setting: an observational study. Diabetes Therapy 2013; 4(2):375-84.
• McDermott MT, ed. Endocrine secrets (6th edition). Philadelphia, Elsevier, 2013 (in press).
• McDermott MT. Overview of the clinical manifestations of Hypothyroidism. In: Braverman LE, Cooper DS, eds. Werner & Ingbar's The Thyroid: a Fundamental and Clinical Text. 10th ed. Philadelphia, PA: Lippincott Williams & Wilkins, 2012, p 569-574
• Lund G, McDermott MT. Oncogenes in thyroid cancer. In: Wartofsky L, Van Nostrand D, eds. Thyroid cancer, a comprehensive guide to clinical management. (3rd ed.). Totowa NJ: Humana Press, 2012
• Golightly LK, Drayna CC, McDermott MT. Comparative clinical pharmacokinetics of dipeptidyl peptidase-4 inhibitors. Clinical Pharmacokinetics 2012 (in press)
• McDermott MT. Does combination LT4/LT3 Therapy make sense? Endocrine Practice (in press)
• McDermott MT. In the Clinic. Hyperthyroidism, Ann Intern Med 2012 (In press)
• McDermott MT. Overview of the clinical manifestations of Hypothyroidism. In: Braverman LE, Cooper DS, eds. Werner & Ingbar's The Thyroid: a Fundamental and Clinical Text. 10th ed. Philadelphia, PA: Lippincott Williams & Wilkins, 2012 (in press)
• Lund G, McDermott MT. Oncogenes in thyroid cancer. In: Wartofsky L, Van Nostrand D, eds. Thyroid cancer, a comprehensive guide to clinical management. (3rd ed.). Totowa NJ: Humana Press, 2012 (in press)
• McDermott MT. Hyperthyroidism, In the Clinic. Ann Intern Med 2012; 157:ITC-1-14
• McDermott MT. Does combination LT4/LT3 Therapy make sense? Endocrine Practice 2012; 18 (5): 750-7
• Golightly LK, Drayna CC, McDermott MT. Comparative clinical pharmacokinetics of dipeptidyl peptidase-4 inhibitors. Clinical Pharmacokinetics 2012; 51 (8): 501-514
• Anderson S, Trujillo J, McDermott M, Saseen J. Determining Predictors of Response to Exenatide in Type 2 Diabetes. J Am Pharm Assoc 2012; 52:466-71
• Kartalija M, Ovrutsky AR, Bryan CL, Pott GB, Fantuzzi G, Thomas J, Strand MJ, Bai X, Ramamoorthy P, Rothman M, Nagabhushanam V, McDermott M, Levin A, Korner J, Iseman MD, Shapiro L, Chan ED. Patients with non-tuberculous Mycobacterial lung disease exhibit a distinct body morphotype with altered cytokine and adipokines profiles. Am J Respir Crit Care Med 2012 Nov 9. [Epub ahead of print]
• Duntas L, Amino N, Hay I, McDermott M, Peeters R, Vaismann M, Ward L, Williams G, San Louis Jr TOL, Yen P. Thyroid disorders, non-communicable diseases that gravely impact public health: a commentary and statement by the Advisory Board of the World Thyroid Federation. Thyroid 2012; 22:566-7.
• Pearce EN, Hennessey JV, McDermott MT. New ATA/AACE guidelines for hyperthyroidism: significant progress for the clinician and a guide to future research. Thyroid 2011; 21:573-6
• McDermott MT. Osteoporosis: An Endocrinologist’s Perspective. VHJOE, September 2010 (E-Pub)
• Vondracek SF, Hansen LB, McDermott MD. Osteoporosis risk in premenopausal women. Pharmacotherapy 2009; 29 (3):305-317.
• Denberg T, Myers BA, Lin CT, Libby AM, Min SJ, McDermott MT, Steiner JF. An outreach intervention increases bone densitometry testing in older women. J Am Geriatric Soc 2009; 57:341-7.
• Denberg T, Myers BA, Eckel RH, McDermott MT, Dickinson WP, Lin CT. A patient outreach program between visits improves diabetes care: a pilot study. Int J Qual Health Care (in press 2009).
• Endocrine Secrets, 5th Edition
• Denberg T, Myers BA, Lin CT, Libby AM, Min SJ, McDermott MT, Steiner JF. An outreach intervention increases bone densitometry testing in older women. J Am Geriatric Soc 2009; 57:341-7.
• Vondracek SF, Hansen LB, McDermott MT. Osteoporosis risk in premenopausal women. Pharmacotherapy 2009; 29 (3):305-317.
• Denberg T, Myers BA, Eckel RH, McDermott MT, Dickinson WP, Lin CT. A patient outreach program between visits improves diabetes care: a pilot study. Int J Qual Health Care 2009; 21(2):130-6.
• Vondracek SF, Voelkel N, McDermott MT, Valdez C. Relationship between adipokines, body composition, and bone mineral density in men with severe chronic obstructive pulmonary disease. International J COPD 2009; 4:267-77.
• McDermott MT. In the Clinic. Hypothyroidism, Ann Intern Med 2009; 151 (11):ITC61
• McDermott MT, ed. Endocrine Secrets (5th edition). Philadelphia: Elsevier, 2009.
• McDermott MT, Ridgway EC. The diagnosis and treatment of hypothyroidism. In: Cooper DS, ed. Practical management of thyroid disorders. New York: Marcel Dekker, Inc., 2009.
• McDermott MT. In the Clinic. Hypothyroidism, Ann Intern Med 2009; 151 (11):ITC61. PMID: 19949140
• Vande Griend JP, Linnebur SA, Ruscin JM, Vondracek SF, McDermott MT. Randomized trial to evaluate the efficacy of a pharmacist-provided educational intervention on serum 25-vitamin D levels in geriatric outpatients. (in press 2008)
• Vondracek SF, Minne P, McDermott MT. Clinical challenges in management of osteoporosis. (in press 2008)
• McDermott MD, ed. Endocrine Secrets (5th edition). Philadelphia: Elsevier, 2008 (In press)
• Vondracek SF, McDermott MT. Osteoporosis. In Voelkel NF, MacNee W, eds. Chronic Obstructive Lung Disease. 2nd Ed. Ontario, Ontario, Canada: BC Decker, Inc. (In press 2008)
• McDermott MT, Ridgway EC. The diagnosis and treatment of hypothyroidism. In: Cooper DS, ed. Practical management of thyroid disorders. New York: Marcel Dekker, Inc., (In press 2008)
• Vondracek SF, Minne P, McDermott MT. Clinical challenges in the management of osteoporosis. Clin Interv Aging 2008; 3(2): 315-29.
• Vande Griend JP, Linnebur SA, Ruscin JM, Vondracek SF, Wolfe P, McDermott MT. Vitamin D intervention by pharmacists in geriatric outpatients. J Am Pharm Assoc 2008; 48:501-7.
• Klopper JP, McDermott MT. Palpable pediatric thyroid abnormalities – diagnostic pitfalls necessitate a high index of clinical suspicion: a case report. J Med Case Reports 2007; 1:29
• Janssen JS, McDermott MT. Update on benign thyroid disorders in women. The Female Patient 32:49-54, 2007.
• Linnebur SA, Vondracek SF, Vande Griend JP, Ruscin JM, McDermott MT. Prevalence of vitamin D insufficiency in ambulatory elderly. Am J Geriatr Pharmacotherapy (In press)
• Janssen JS, McDermott MT. Update on benign thyroid disorders in women. The Female Patient 32:49-54, 2007.
• Linnebur SA, Vondracek SF, Vande Griend JP, Ruscin JM, McDermott MT. Prevalence of vitamin D insufficiency in ambulatory elderly. Am J Geriatr Pharmacotherapy 2007; 5:1-8.
• Golightly LK, Jones MA, Hamamura DH, Stolpman NM, McDermott MT. Management of diabetes mellitus in hospitalized patients: efficiency and effectiveness of sliding-scale insulin therapy. Pharmacotherapy 26:1421-32, 2006.
• Gharib H, Tuttle MR, Baskin HJ, Fish L, Singer PA, McDermott MT. Subclinical thyroid dysfunction: a joint statement on management from The American Association of Clinical Endocrinologists, The American Thyroid Association, and The Endocrine Society. J Clin Endocrinol Metab 90:581-5, 2005; Thyroid 2005; 15:24-8. Endocrine Practice [jointly published in all 3 journals]
• Weber K, McDermott MT. Oncogenes in Thyroid Cancer. In: Wartofsky L, ed. Thyroid cancer, a comprehensive guide to clinical management. Second Ed. Totowa NJ: Humana Press. 2005
• 91. Santoro N, Braunstein GD, Butts CL, Martin KA, McDermott M, Pinkerton JV. Compounded Bioidentical Hormones in Endocrinology Practice: An Endocrine Society Scientific Statement. J Clin Endocrinol Metab 2016 (in press)
• McDermott MT. Pseudo-endocrine disorders: recognition, management and action. J Endocrine Soc (in press).
• McDermott MT, ed. Endocrine Secrets (8th edition). Philadelphia, Elsevier, 2025 (in press)
• Trujillo JM, Ellis SL, Nuffer WA, Wettergreen SA, McDermott MT. Cardiovascular outcomes of new medications for type 2 diabetes. Diab Technol Therapeut. (in press)
• Vigersky RA, Fish L, Hogan P, Hupart K, Kutler S, Ladenson P, McDermott M, Stewart A. The Clinical Endocrinology Workforce: Current Status and Future Projections of Supply and Demand. J Clin Endocrinol Metab (in press)
• Santoro N, Braunstein GD, Butts CL, Martin KA, McDermott M, Pinkerton JV. Compounded Bioidentical Hormones in Endocrinology Practice: An Endocrine Society Scientific Statement. J Clin Endocrinol Metab (in press)
• Nuffer W, Gilliam E, McDermott M, Turner CJ. Sustainability of a practice-based interprofessional introductory pharmacy practice experience course. Am J Pharmaceutical Edu (in press)

Professional Memberships

• Endocrine Society, Member
• American College of Physicians (ACP), Master
• American Diabetes Association, Member
• American Society for Bone and Mineral Research, Member
• American Thyroid Association (ATA) , Member
• American Association of Clinical Endocrinologists, Member

Practice Locations

UCHealth Anschutz Outpatient Pavilion - Anschutz Medical Campus
1635 Aurora Ct
Aurora, CO 80045
720-848-0000

UCHealth Diabetes and Endocrinology Clinic - Anschutz Medical Campus
1635 Aurora Ct
6th Floor
Aurora, CO 80045
720-848-2650

Hospital Affiliation

• University of Colorado Hospital

Specialty Information

Specialties

• Endocrinology, Diabetes and Metabolism, Board Certification (1983)
• Internal Medicine, Board Certification (1980)

Conditions & Treatments

• Endocrine System (Hormones) - Adult Type 1 Diabetes
• Endocrine System (Hormones) - Adult Type 2 Diabetes
• Endocrine System (Hormones) - Endocrine Cancer (Parathyroid, Adrenal, Carcinoid)
• Endocrine System (Hormones) - Thyroid Cancer
• Endocrine System (Hormones) - Thyroid Disease
• Endocrine System (Hormones) - Adrenal Diseases
• Endocrine System (Hormones) - Lipidosis
• Endocrine System (Hormones) - Osteoporosis
• Endocrine System (Hormones)